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A recent hospital outbreak related to premoistened gloves 
used to wash patients exposed the difficulties of defining 
Burkholderia species in clinical settings. The outbreak strain 
displayed key B. stabilis phenotypes, including the inabil-
ity to grow at 42°C; we used whole-genome sequencing to 
confirm the pathogen was B. stabilis. The outbreak strain 
genome comprises 3 chromosomes and a plasmid, shar-
ing an average nucleotide identity of 98.4% with B. stabilis 
ATCC27515 BAA-67, but with 13% novel coding sequenc-
es. The genome lacks identifiable virulence factors and has 
no apparent increase in encoded antimicrobial drug resis-
tance, few insertion sequences, and few pseudogenes, 
suggesting this outbreak was an opportunistic infection by 
an environmental strain not adapted to human pathogenic-
ity. The diversity among outbreak isolates (22 from patients 
and 16 from washing gloves) is only 6 single-nucleotide 
polymorphisms, although the genome remains plastic, with 
large elements stochastically lost from outbreak isolates. 
Burkholderia is a diverse genus of gram-negative bac-teria, with isolates identified from a variety of envi-
ronments, and ever more species being identified and 
classified. Whereas some Burkholderia species are associ-
ated with bioremediation potential and antimicrobial and 
antifungal production, others are animal and human 
pathogens that generally fall within the B. cepacia com-
plex (Bcc) (1). Burkholderia bacteria have large, flexible, 
multi-replicon genomes, a large metabolic repertoire, vari-
ous virulence factors, and inherent resistance to many anti-
microbial drugs (2,3).
An outbreak of B. stabilis was identified among hos-
pitalized patients across several cantons in Switzerland 
during 2015–2016 (4). The bacterium caused bloodstream 
infections, noninvasive infections, and wound contamina-
tions. The source of the infection was traced to contaminat-
ed commercially available, premoistened washing gloves 
used for bedridden patients. After hospitals discontinued 
use of these gloves, the outbreak resolved. 
Many instances of Bcc strain contamination of medical 
devices and solutions have been described (4), including an 
outbreak in Korea associated with a 0.5% chlorhexidine so-
lution (5). B. stabilis also has been identified in nosocomial 
infections (6–8).
We conducted in-depth characterization of the B. sta-
bilis strain from the Switzerland outbreak by using clinical 
methods and whole-genome sequencing (WGS). We gen-
erated a complete draft genome by combining short- and 
long-read genomic data and compared it to other outbreak 
isolates to provide a complete genomic assessment of this 
strain. We provide a thorough comparative genomic analy-
sis of this outbreak strain.
Methods
Bacterial Isolate Collection
Isolates were collected from 22 patients (labeled 1–22) 
and 16 contaminated washing gloves (labeled A–P) across 
Switzerland during the outbreak (4). For comparison, we 
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collected 14 unrelated Burkholderia spp. patient isolates in 
Switzerland (labeled O-1 through O-14; Appendix 1 Table 
1, https://wwwnc.cdc.gov/EID/article/25/6/17-2119-App1.
xlsx). We obtained a control strain, B. stabilis ATCC27515 
BAA-67, isolated in 1993 from sputum of a patient with 
cystic fibrosis in Belgium, from the American Type Culture 
Collection (ATCC, https://www.atcc.org).
Clinical Diagnostics
We performed routine identification using matrix-assisted la-
ser desorption/ionization time-of-flight (MALDI-TOF) mass 
spectrometry and biochemical species identification. For 
MALDI-TOF mass spectrometry, we used Biotyper MBT 
Smart (Bruker Corporation, https://www.bruker.com) with 
flexControl and MBT Compass version 4.1 software. We con-
sidered scores >2.0 high confidence identification and scores 
of 1.7–2.0 low confidence identification. We used VITEK 2 
gram negative identification card (bioMérieux, https://www.
biomerieux.com) for biochemical species identification. Phe-
notypic antimicrobial resistance profiles were determined 
using disk diffusion. We interpreted breakpoints according 
to Clinical and Laboratory Standards Institute (9) standards 
for Bcc (ceftazidime, trimethoprim/sulfamethoxazole, and 
meropenem) or Enterobacteriaceae (aminoglycosides, cip-
rofloxacin, piperacillin/tazobactam, and other β-lactams). We 
used XbaI to digest DNA before using previously described 
pulsed-field gel electrophoresis (PFGE) molecular typing 
principles (10). We used GelCompar (Applied Maths, http://
www.applied-maths.com) to analyze PFGE results.
Cellular Fatty Acid Analysis
We prepared and derivatized cellular fatty acids from out-
break isolates 7, 13, and O, with control strain Pseudomo-
nas aeruginosa strain ATCC27853, as previously described 
(11). We performed chromatography on an HP 6890 gas 
chromatograph (Hewlett Packard Enterprise, https://www.
hpe.com) and analyzed data in SHERLOCK MIS version 
6.2 (Midi Inc., http://midi-inc.com).
Genome Sequencing, Assembly, Annotation,  
and Mapping
We extracted DNA using EZ1 Advanced XL (QIAGEN, 
https://www.qiagen.com) or Wizard Genomic DNA Pu-
rification kit (Promega, https://www.promega.com) and 
then sequenced it on the Illumina MiSeq platform (https://
www.illumina.com) following Nextera XT library creation 
within the Division of Clinical Microbiology, University 
Hospital Basel (300-bp paired-end reads) or the Unit of Ge-
nomics of the Institute of Microbiology, Lausanne Univer-
sity Hospital (150-bp paired-end reads). We mapped data 
against the genome of B. cepacia ATCC25416 (GenBank 
accession nos. CP007746–8) for quality control and cov-
erage determination (Appendix 1 Table 1). We sequenced 
DNA from outbreak isolate 5 on a PacBio RS II platform 
(Pacific Biosciences, https://www.pacb.com) with 1 SMRT 
cell at the Functional Genomics Centre, Zurich. We sub-
mitted read data for all samples to the European Nucleotide 
Archive under project nos. PRJEB18658 and PRJEB19203 
(data previously analyzed; 12). 
We used CLC Genomics Workbench 9 (https://clc-ge-
nomics-workbench.software.informer.com/9.0) to assem-
ble Illumina reads from outbreak isolate E (1,736 contigs; 
assembly length 8,816,302 bp) and from unrelated isolates. 
We processed PacBio reads with CLC Genomics Work-
bench 9 using an error correction of 30 or 50 and assembled 
resulting reads or used them to correct the Illumina assem-
bly of E. We used Spades version 3.10.0 (13) to assemble 
the PacBio reads with Illumina reads from isolates E or 5. 
We manually compared assemblies in Artemis and ACT 
(14,15) to circularize and split chromosomes 1 and 2 ac-
cording to the genome of B. stabilis BAA-67 (GenBank ac-
cession nos. CP016442–4) (16). We found chromosome 3 
is a single contig that was not obviously circularizable. We 
used Prokka version 1.11 (17) for automated annotation 
and manually curated coding sequences (CDSs) by using 
Artemis and ACT. We submitted the genome draft to ENA 
under accession no. ERZ480954.
We performed mapping in CLC Genomics Workbench 
9, which we also used to generate k-mer trees (18) using 
default parameters. For single-nucleotide polymorphism 
(SNP) phylogenies, we used variant calling with 5× mini-
mum coverage, 5 minimum count, and 70% minimum fre-
quency and created SNP trees with 5× minimum coverage, 
5% minimum coverage, 0 prune distance, and multinucleo-
tide variants.
Database and Genome Comparisons
We used multilocus sequence typing (MLST; https://cge.
cbs.dtu.dk/services/MLST) to identify alleles from as-
semblies of isolate E and unrelated Burkholderia spp. (19) 
and compared these against Bcc MLST databases (https://
pubmlst.org/bcc) (20) for species designation. We per-
formed average nucleotide identity (ANI) determination 
using the ANI calculator (http://enve-omics.ce.gatech.edu/
ani) (21), and digital DNA-DNA hybridization (dDDH) 
with GGDC2.1 (http://ggdc.dsmz.de/distcalc2.php) (22). 
We used antiSMASH version 4.0.0 (https://antismash.
secondarymetabolites.org) (23) to predict gene clusters in-
volved in antimicrobial resistance and secondary metabo-
lite production.
Results
Clinical and Major Fatty Acid Characterization
We analyzed outbreak and unrelated Burkholderia spp. 
isolates by PFGE (Appendix 2 Figure 1, https://wwwnc.
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cdc.gov/EID/article/25/6/17-2119-App2.pdf). PFGE pat-
terns of outbreak isolates from patients and washing gloves 
formed a cluster separate from the unrelated isolates. Out-
break isolates shared 75.7% similarity by Pearson corre-
lation analysis; previous studies used a value of 80% for 
outbreak grouping (24).
We conducted MALDI-TOF mass spectrometry on 
12 outbreak isolates and identified B. cepacia group (n 
= 4), B. stabilis (n = 4), B. multivorans (n = 2), B. ceno-
cepacia (n = 1), and B. pyrrocinia (n = 1) with scores 
of 1.88–2.21. Because MALDI-TOF mass spectrometry 
is known to misidentify Bcc species (25), we used VI-
TEK 2 to conduct biochemical testing on isolates from 
3 patients and 1 washing glove and identified either Bcc 
group (scores of 91%–95%) or Acinetobacter lwoffii 
(scores of 86%–91%). 
Our outbreak isolates and control strain shared a de-
fining characteristic of B. stabilis, the inability to grow at 
42°C (26). Using VITEK 2, we saw 2 other key charac-
teristics of B. stabilis in the outbreak strain, absence of 
β-galactosidase activity and inability to oxidize sucrose 
(Table 1). In contrast to other B. stabilis strains, VITEK 
2 showed our strain was negative for adonitol acidifica-
tion, ornithine decarboxylase, and lysine decarboxylase. 
Phenotypic identification of Burkholderia spp. often is 
a tedious process (26), with high rates of misidentifica-
tion because of false negative reporting by VITEK 2 (29). 
Clinical standard identification on the VITEK 2 runs up to 
16 hours, but Burkholderia phenotypes can take up to 7 
days to develop. Our subsequent genome analysis identi-
fied genes encoding ornithine decarboxylase and lysine 
decarboxylase in the outbreak strain.
Cellular fatty acid profiling of 3 outbreak isolates 
showed profiles highly similar to the reference strains B. 
stabilis and B. cepacia (26,30), and expectedly distinct 
from control strain P. aeruginosa strain ATCC27853 (Ap-
pendix 1 Table 2; Appendix 2 Figure 2). Together, these 
assays identified the outbreak strain as a member of the 
genus Burkholderia within Bcc but did not enable a firm 
species-level identification.
Identification of Outbreak Isolate Clade in Bcc
We conducted WGS on 22 patient isolates and 16 isolates 
from washing gloves. We compared a full-length 16S 
rRNA gene sequence derived from the genome assembly 
of isolate E against the National Center for Biotechnolo-
gy Information nucleotide sequence database using blastn 
(http://blast.ncbi.nlm.nih.gov). We identified 2 top hits, 
both sharing 1,520 out of 1,521 nt identities, B. pyrrocinia 
DSM10685, and B. stabilis BAA-67. Many other Bcc spe-
cies shared >99% nucleotide identity, including B. stagnalis 
MSMB735WGS, B. cenocepacia AU1054, B. cenocepacia 
J2315, B. ambifaria AMMD, and B. lata 383. We mapped 
the WGS data of all outbreak isolates against a draft as-
sembly of isolate E and found 99%–100% coverage from 
all isolates, but only 60%–75% coverage from unrelated 
isolate sequences (Appendix 1 Table 1). K-mer analysis 
of outbreak and unrelated Burkholderia isolates showed a 
separate cluster of outbreak isolates (Appendix 2 Figure 3).
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Table 1. Biochemistry of Burkholderia stabilis outbreak strain from 
3 patient isolates and 1 environmental isolate collected from 








Saccharose, sucrose‡ – 4 – 
β-galactosidase‡ – 4 – 
Maltose acidification + 3 + 
Adonitol acidification – 4 + 
Ornithine decarboxylase – 4 + 
Lysine decarboxylase – 4 + 
D-mannitol – 4 + 
D-glucose + 4 + 
D-cellobiose + 4 + 
Malonate – 4 + 
D-sorbitol – 4 + 
Urease – 4 + or – 
*Performed using VITEK 2.  
†From (26,28). 
‡Specific discriminatory test for B. stabilis. 
 
 
Table 2. Genome comparisons of Burkholderia stabilis outbreak strain CH16 from Switzerland against Burkholderia reference strains* 









B. stabilis ATCC BAA-67 IV CP016442–4 98.4 87.8 94.98 0.08 
B. pyrrocinina DSM10685 IX CP011503–6 92.9 49.4 17.44 0.17 
B. stabilis LA20W§ IV GCA_001685505.1 92.5 49.3 17.3 0.16 
B. lata 383 
 
NC_007509–11 91.4 44.7 7.72 0.12 
B. cepacia ATCC25416 I NZ_CP012981–3 91.3 44.5 7.52 0.37 
B. cenocepacia J2315 III AM747720–3 91.1 44 6.68 0.55 
B. ambifaria AMMD VII NZ_CP009798–800 89.8 39.9 2.65 0.44 
B. latens AU17928 
 
CP013435–8 88.8 37 1.22 0.03 
B. dolosa AU0158 VI CP009793–5 88.8 37.2 1.27 0.66 
B. vietnamensis LMG10929 V CP009629–32 88.5 36.2 0.97 0.48 
B. multivorans DDS 15A-1 II CP008728–30 88.3 36 0.89 0.25 
B. multivorans BAA247 II CP009830–2 88.1 35.3 0.71 0.9 
*ANI, average nucleotide identity; dDDH, digital DNA-DNA hybridization. 
†Species cutoff 95%.  
‡Species cutoff 70%. 
§From these results, strain LA20W should not be classified as B. stabilis. 
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Identification of New B. stabilis Strain
We used MLST to extract alleles from the genome draft to 
obtain a new sequence type (ST), 1095, with the following 
genes: atpD (380, new), gltB (456), gyrB (213), lepA (70), 
phaC (348, new), recA (109), trpB (173). The top matches 
to this MLST profile are all B. stabilis isolates sharing <4 
of the 7 alleles. The matching isolates are from Canada, 
which had 4 matching alleles; and Czechia, Serbia, China, 
France, Italy, and the United Kingdom, each with 2 match-
ing alleles, including the B. stabilis type strain ATCC27515 
BAA-67.
We used ANI calculations of genomic relatedness to 
compare the isolate E genome draft to a comprehensive 
panel of sequenced Bcc strains (Table 2). B. stabilis BAA-
67 is the most closely related with an ANI of 98.4%, which 
is above the species cutoff of 95% (31). In addition, dDDH 
comparing the outbreak strain to the Bcc panel showed that 
the maximum score of the outbreak genome is with B. sta-
bilis BAA-67 at 84.2%, with the classic species threshold 
at 70%. These genomic parameters currently are the most 
robust for species designation (32–34) and we are confident 
that the outbreak strain belongs to the species B. stabilis. 
The high dDDH score might reflect the high genome con-
servation within this species, giving it its name (26).
Description of Draft of B. stabilis Strain CH16
A hybrid assembly of PacBio and Illumina data resulted 
in an improved, high-quality genome draft (35) of the out-
break strain, named CH16 because it occurred in Switzer-
land in 2016. This draft comprises 1 contig for each of the 3 
chromosomes. Comparison with the genome of B. stabilis 
BAA-67 (16) showed that the genomes are syntenic with 
the exception of a rearrangement on chromosome 1 be-
tween the rRNA operons, which might be a real inversion 
or an assembly artifact in 1 of the genomes (Figure 1). We 
detected a separate contig representing a predicted plasmid 
sequence, whereas none was found within strain BAA-67 
(J. Bugrysheva, US Centers for Disease Control and Pre-
vention, pers. comm., 2017 Jan 10) (Table 3).
In addition to being large and multireplicon, Burkhold-
eria genomes are characterized by the presence of multiple 
phages, genomic islands, and insertion sequences (IS ele-
ments) (3). The draft genome CH16 contains many inser-
tions of single or multiple genes relative to strain BAA-
67: 16 on chromosome 1; 34 on chromosome 2; and 10 on 
chromosome 3 (Figure 1). Appendix 1 Table 3 lists regions 
of difference (RDs).
The B. stabilis CH16 genome has a paucity of IS el-
ements. We have identified only 40, including 6 families 
with copy numbers of 3–12 (Appendix 1 Table 4), that 
cause disruption of 9 CDSs (Appendix 1 Table 5). CH16 
did not appear to be experiencing IS element expansion, 
which is associated with genome rearrangements, large- 
scale genomic deletions, and niche adaptation (36–38), 
but it has the potential for IS element expansion if it goes 
through a population bottleneck. 
Frameshifts and premature stop codons have created 11 
additional pseudogenes (Appendix 1 Table 5). The 20 pseu-
dogenes of CH16 contrast with 142 annotated in the genome 
of strain BAA-67, indicating that most of the CH16 genome 
is required for survival in diverse environments and that this 
strain is not adapting to a pathogenic lifestyle.
RDs and Virulence Factors of B. stabilis Strain CH16
Using genome-wide blastn comparisons, we determined 
that the CH16 genome carries 973 novel CDSs relative to 
BAA-67 of the total 7,629 CDSs (12.7%; Appendix 1 Table 
3), many of which are novel to all Burkholderia sequenced 
to date. Larger insertions containing >40 CDSs are putative 
phages or integrative and conjugative elements. Smaller in-
sertions of <10 CDSs appear to represent deletions in the 
BAA-67 strain relative to their common ancestor.
Factors that might contribute to the virulence of 
CH16 include adhesins and hemaglutinins, including 
BSTAB16_1184, _5825, _5829, _5874, _6110, _6684, 
_6804, and _6861, of which most have homologs in other 
Bcc strains; and Type II and Type VI secretion systems 
(BSTAB16_4657–74, _5069–91, and _5583–9). The many 
regulators within the CH16 genome and the RDs provide 
additional layers of translational control necessary in a 
genome of this size. We saw no evidence of the known 
Burkholderia virulence factors cable pilus or B. cepacia 
epidemic strain marker (36). The toxins we identified, for 
example BSTAB16_5843 containing the HipA domain, are 
antibacterial toxins rather than virulence factors.
The many efflux pumps found in the CH16 genome 
might explain its ability to grow in the wash solution, 
including members of the following families: resistance nod-
ulation and cell division, ATP-binding cassette, small mul-
tidrug resistance, multidrug and toxic compound extrusion, 
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Table 3. General properties of genome draft for Burkholderia 
stabilis strain CH16 from Switzerland* 
Property Value 
Draft genome size, bp 8,505,958 
Chromosomes  3  
Chromosome sizes, bp 3,705,321; 3,499,410; 1,230,432 
Plasmid size, bp 70,922 
% G+C content 66.3 
Predicted CDSs (per 
chromosome and plasmid) 
7,629 (3,402; 3,068; 1,075; 84) 
Coding density 86.40% 
Average gene length 965 bp 
Pseudogenes 20 
rRNA operons 6 
tRNAs 75 
Insertion elements 40 
*CDSs, coding sequences. 
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and major facilitator superfamily. Several secondary metabo-
lite synthesis pathways are predicted: 4 on chromosome 1; 5 
on chromosome 2; and 5 on chromosome 3 (Appendix 1 Ta-
ble 6). Most of these are shared with the BAA-67 reference 
genome, encoding the ability to produce signaling molecules, 
siderophores, terpenes, and a bacteriocin, among others.
The plasmid comprises largely novel sequences not 
seen before within the Burkholderia or elsewhere. It carries 
genes predicted to be involved in conjugation, indicating 
that it might be a mobile plasmid, such as 1 recently hy-
pothesized in B. cenocepacia (39). The rest of the plasmid 
largely comprises genes encoding hypothetical proteins.
Antimicrobial Drug Resistance of B. stabilis  
Strain CH16
We performed phenotypic antimicrobial drug susceptibil-
ity testing on a subset of outbreak isolates (Appendix 1 
Table 7) and used genomic findings to interpret the results. 
Breakpoints are not established clinically and are not rec-
ommended to guide patient therapy (40).
All Bcc isolates are intrinsically resistant to amino-
glycosides (40), which we confirmed in our isolates. In-
trinsic resistance also is described against chlorampheni-
col and tetracycline (40) (not tested) through the presence 
of efflux pumps. We identified several efflux pumps 
within the CH16 genome (BSTAB16_5335–6, _4605–6, 
and _7210–1), none of which are unique to the outbreak 
strain. Sensitivity to trimethoprim/sulfamethoxazole was 
a feature of the outbreak isolates; we did not identify trim-
ethoprim/sulfamethoxazole resistance determinants in the 
draft genome.
Bcc is considered to be intrinsically and clinically re-
sistant to many β-lactams through impermeability and the 
presence of inducible β-lactamases (40). All Bcc isolates 
tested were resistant to aminopenicillins, carboxypeni-
cillins, and first-generation cephalosporins. Phenotypic 
resistance to third-generation cephalosporins, ureidope-
nicillins, and carbapenems was more variable among Bcc. 
We identified several β-lactamases in the CH16 genome, 
representing class A (BSTAB16_4862 and _4440), class C 
(BSTAB16_6957), class D (BSTAB16_5918), and metallo-
β-lactamases (BSTAB16_ 3974 and _5115), none of which 
are unique to this strain.
The outbreak isolates are sensitive to ciprofloxacin, 
in contrast to B. stabilis BAA-67, with sporadic resis-
tance seen among other Bcc isolates. Resistance can be 
associated with efflux (40) or specific mutations in gyrA 
(BSTAB16_1445). The gyrA of CH16 differs from that of 
strain BAA-67 at I83T and A700S (numbered according to 
E. coli). In general, this strain does not display enhanced 
antimicrobial resistance compared with other clinical Bcc 
isolates or B. stabilis BAA-67 (2,41,42).
Of note, some of the outbreak isolates had anoma-
lous antibiograms, which we confirmed through repeated 
testing (Appendix 1 Table 7). This finding might relate 
to colony morphology because several morphotypes 
were observed during clinical work on the outbreak 
isolates. This phenomenon is known to occur within 
Burkholderia (43–46), resulting from reversible colony 
morphotype switching (44) or stable mutations (43,46). 
Altered genes often are involved in exopolysaccharide 
production, also causing changes in biofilm production, 
virulence, resistance, and motility (43–46), and might 
result from stress (44,45).
Comparison of Outbreak Isolates
PFGE and k-mer analyses showed that the outbreak iso-
lates cluster. We investigated how related the isolates are 
by comparing genomes using high-quality SNPs. The SNP 
phylogeny (Figure 2) indicates a maximum of 6 SNPs 
between isolates from the outbreak source, in agreement 
with Abdelbary et al. (12). The previously published core 
genome MLST (cgMLST) phylogeny used the same ge-
nome data but indicated up to 18 alleles difference be-
tween isolates (4), though these are likely artifacts of the 
methodology (47).
Washing glove isolates were located throughout the 
phylogeny; we observed diversity within a lot number 
(isolates E–F and L–O), and even within single packets 
(isolates A, B, and L–O). Patient samples also were found 
throughout the phylogeny, even those originating from the 
same city (isolates 5, 7, 9–13 are from a first city; 6, 8, 21, 
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Figure 1. Comparison of the genome of Burkholderia stabilis strain CH16 from Switzerland (top bar) with that of B. stabilis reference 
strain BAA-67 (bottom bar). Alternating orange and brown bar sections represent chromosomes 1, 2, 3, and a plasmid. Scale bar 
indicates identity between the genomes (determined by blastn, http://blast.ncbi.nlm.nih.gov). Colors above the CH16 genome indicate 
the following: purple, regions of difference between the 2 strains; green, putative integrative and conjugative element; blue, phage; and 
red, the plasmid. 
Analyses of Burkholderia stabilis Contamination
and 22 are from a second city; and 14–20 are from a third 
city), reflecting trends seen from cgMLST data (4).
SNP locations (Appendix 1 Table 8) indicate that, of 
the 40 nonsynonymous SNPs, 15 are in genes predicted to 
encode regulators, 6 in transporters, and 3 in flagellin. We 
could not tell whether these are random mutations or have 
been subject to selective pressure, but all classes are repre-
sented in both glove and patient isolates.
In addition to the SNPs, we saw some large-scale 
genomic differences. By mapping read data against each 
individual replicon, we noted that isolates E and 20 do 
not carry the plasmid, which appears to be a stochastic 
event because the SNP phylogeny indicates that these 
isolates are not derived from a common ancestor. Iso-
lates D and E have highly similar PFGE patterns (Ap-
pendix 2 Figure 1), suggesting that the plasmid does 
not affect the PFGE results or was lost during labora-
tory culture. Patient isolate 22 also shows the loss of 
the first 52.5 kb of chromosome 3, representing an RD, 
which this isolate apparently lost spontaneously during 
the course of the outbreak. Because of this genome plas-
ticity, we hypothesize the CH16 genome was changing 
even during the course of the outbreak.
Discussion
We provide a thorough and detailed description of a Bur-
kholderia sp. outbreak resolved by WGS (4) and illustrate 
various associated challenges, including morphotype dif-
ferences, species designation, and a large genome with as-
sociated assembly, annotation, and interpretation issues. 
Defining species within Bcc is notoriously difficult (26), 
whether phenotypically by using biochemical or MALDI-
TOF mass spectrometry profiles, genomically by using 
16S rRNA gene sequences, or both. WGS provides the 
most thorough analysis and is increasingly cost and time 
effective, even compared with sequencing MLST loci, in-
terpretation of which also is complex. We saw anomalies 
between the phenotype of this B. stabilis outbreak strain 
and those described in the literature (26,27) due to shorter 
than optimal test incubation times in standard clinical phe-
notyping (29).
Several techniques can be used on WGS data to provide 
phylogenies. K-mer analysis (Appendix 2 Figure 3) pro-
vides an indication of clustering, but the branch lengths can-
not be relied on to provide a true phylogeny and do not truly 
reveal relationships within clades. With this technique, a lot 
of genomic information regarding the coding capacity of the 
genome is lost. cgMLST compares nucleotide sequences of 
CDSs common to a group of isolates, linking isolates with 
the highest numbers of identical alleles. During this process 
some genomic data necessarily are lost, with information 
from accessory genes and intergenic regions disregarded. 
However, both methods can be performed routinely with 
minimal training to enable rapid visualization of outbreak 
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Figure 2. Phylogeny 
of outbreak isolates of 
Burkholderia stabilis strain 
CH16 from Switzerland 
based on high-quality single 
nucleotide polymorphisms 
(SNPs). This phylogeny 
of all sequenced outbreak 
isolates might represent a 
conservative estimate of SNP 
numbers. Given the large 
genome size and possible 
mismapping to repeats, it 
is difficult to determine the 
ultimate number of SNPs 
between samples. This 
phylogeny was confirmed 
using several parameters and 
manual checking of called 
SNPs. The root was arbitrarily 
chosen to give the fewest root 
to tip SNPs (n = 6). Numbers 
represent isolates from 
patients; letters represent 
isolates from washing gloves, 
located in the root position. 
Scale bar indicates 1 SNP.
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clusters. Comparing reads from all outbreak isolates to an 
assembled draft genome to generate a SNP phylogeny in-
cludes all genomic information but requires more computa-
tion, time, and expertise. 
WGS is the optimal way to determine the detailed rela-
tionships between isolates, giving insights into an outbreak 
and providing a basis from which to develop further typing 
methods. For future cases, we suggest rapid WGS, extrac-
tion of MLST alleles from assemblies for species identifi-
cation as recommended by Mahenthiralingam et al. (48), 
and cgMLST typing for rapid outbreak identification. SNP 
detection can be a valuable subsequent step to determine 
accurate relatedness of isolates.
Bcc bacteria are known to survive in pharmaceuti-
cal and disinfectant materials (1,48,49). B. stabilis strains 
sharing MLST types can be isolated from the natural en-
vironment, hospitals, and patients (50), implicating the 
natural environment as a source of opportunistic Burk-
holderia and emphasizing the versatility of Bcc to survive 
and grow under diverse conditions. The CH16 genome 
displays features representative of Burkholderia in gen-
eral; it is large, highly plastic, and contains many novel 
elements that might be involved in pathogenesis or envi-
ronmental survival (36). The low number of pseudogenes 
and IS elements indicates that this strain has not under-
gone niche adaptation, and most likely is an opportunistic 
pathogen (36–38).
The cloud of diversity seen in the SNP phylogeny indi-
cates that the source of the original contamination was not 
clonal or that several mutations occurred during the incuba-
tion of CH16 within the patient washing gloves. The loss 
of genomic elements, including the plasmid, from some of 
the isolates, also demonstrates the flexibility and the re-
dundancy within such a large genome. Our study shows 
the importance of WGS in investigating and resolving this 
outbreak, which appears to have been caused by an envi-
ronmental Bcc strain.
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